Jill S Bates

7PUBLICATIONS
9CO-AUTHORS
PharmacogenomicsIntensive careCommunity and primary careAcute careCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 22, 2024
Association of Pharmacogenomic Phenotypes in CYP2D6, CYP2C9, CYP2C19, and CYP3A5 on Polypharmacy in Veterans.

Linas Krulikas, Jill Bates, Catherine Chanfreau

|Apr 16, 2020
Evaluation and optimization of a clinical pharmacist driven transitions of care model for malignant hematology.

Lucas S Wind, Thomas G Knight, Jessica J Auten

|Jul 11, 2019
Demonstrating the value of the oncology pharmacist within the healthcare team.

Eve M Segal, Jill Bates, Sara L Fleszar

|May 18, 2019
A chemotherapy privileging process for advanced practice providers at an academic medical center.

Michelle A Carrasquillo, Tyler A Vest, Jill S Bates

|Feb 28, 2019
Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation.

Jill S Bates, Jessica Auten, Margaret R Sketch

|Dec 04, 2018
A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasone.

Allison J Schepers, Alexis R Jones, Brandi N Reeves

Pageof 2